These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 28378780)

  • 1. A Fluorometric Method of Measuring Carboxypeptidase Activities for Angiotensin II and Apelin-13.
    Liu P; Wysocki J; Serfozo P; Ye M; Souma T; Batlle D; Jin J
    Sci Rep; 2017 Apr; 7():45473. PubMed ID: 28378780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of prolyl carboxypeptidase as an alternative enzyme for processing of renal angiotensin II using mass spectrometry.
    Grobe N; Weir NM; Leiva O; Ong FS; Bernstein KE; Schmaier AH; Morris M; Elased KM
    Am J Physiol Cell Physiol; 2013 May; 304(10):C945-53. PubMed ID: 23392115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism.
    Rice GI; Thomas DA; Grant PJ; Turner AJ; Hooper NM
    Biochem J; 2004 Oct; 383(Pt 1):45-51. PubMed ID: 15283675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of renin-angiotensin system enzyme activities in cultured mouse podocytes.
    Velez JC; Bland AM; Arthur JM; Raymond JR; Janech MG
    Am J Physiol Renal Physiol; 2007 Jul; 293(1):F398-407. PubMed ID: 17429035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin processing is partially carried out by carboxypeptidases in the rat mesenteric arterial bed perfusate.
    Pereira HJ; Souza LL; Salgado MC; Oliveira EB
    Regul Pept; 2008 Nov; 151(1-3):135-8. PubMed ID: 18838088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New mass spectrometric assay for angiotensin-converting enzyme 2 activity.
    Elased KM; Cunha TS; Gurley SB; Coffman TM; Morris M
    Hypertension; 2006 May; 47(5):1010-7. PubMed ID: 16585421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of renin-angiotensin system blockade on renal angiotensin-(1-7) forming enzymes and receptors.
    Ferrario CM; Jessup J; Gallagher PE; Averill DB; Brosnihan KB; Ann Tallant E; Smith RD; Chappell MC
    Kidney Int; 2005 Nov; 68(5):2189-96. PubMed ID: 16221218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primacy of cardiac chymase over angiotensin converting enzyme as an angiotensin-(1-12) metabolizing enzyme.
    Ahmad S; Varagic J; VonCannon JL; Groban L; Collawn JF; Dell'Italia LJ; Ferrario CM
    Biochem Biophys Res Commun; 2016 Sep; 478(2):559-64. PubMed ID: 27465904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carboxypeptidases A1 and A2 from the perfusate of rat mesenteric arterial bed differentially process angiotensin peptides.
    Pereira HJ; Souza LL; Costa-Neto CM; Salgado MC; Oliveira EB
    Peptides; 2012 Jan; 33(1):67-76. PubMed ID: 22178042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biosynthesis and physio-pharmacological actions of angiotensin peptides: 1. Synthetic enzymes.
    Haulică I; Bild W; Rădăşanu O
    Rev Med Chir Soc Med Nat Iasi; 2006; 110(1):167-72. PubMed ID: 19292099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased angiotensin-(1-7)-forming activity in failing human heart ventricles: evidence for upregulation of the angiotensin-converting enzyme Homologue ACE2.
    Zisman LS; Keller RS; Weaver B; Lin Q; Speth R; Bristow MR; Canver CC
    Circulation; 2003 Oct; 108(14):1707-12. PubMed ID: 14504186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrarenal alterations of the angiotensin-converting enzyme type 2/angiotensin 1-7 complex of the renin-angiotensin system do not alter the course of malignant hypertension in Cyp1a1-Ren-2 transgenic rats.
    Husková Z; Kopkan L; Červenková L; Doleželová Š; Vaňourková Z; Škaroupková P; Nishiyama A; Kompanowska-Jezierska E; Sadowski J; Kramer HJ; Červenka L
    Clin Exp Pharmacol Physiol; 2016 Apr; 43(4):438-49. PubMed ID: 26833491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adhesion ability of angiotensin II with model membranes.
    Preu J; Tiefenauer L; Gutberlet T
    Biochim Biophys Acta Biomembr; 2017 Feb; 1859(2):195-200. PubMed ID: 27865700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin-converting enzyme-2 (ACE2): comparative modeling of the active site, specificity requirements, and chloride dependence.
    Guy JL; Jackson RM; Acharya KR; Sturrock ED; Hooper NM; Turner AJ
    Biochemistry; 2003 Nov; 42(45):13185-92. PubMed ID: 14609329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alteration of the renin-angiotensin system in caerulein induced acute pancreatitis in the mouse.
    Gaddam RR; Ang AD; Badiei A; Chambers ST; Bhatia M
    Pancreatology; 2015; 15(6):647-53. PubMed ID: 26444748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin metabolism in renal proximal tubules, urine, and serum of sheep: evidence for ACE2-dependent processing of angiotensin II.
    Shaltout HA; Westwood BM; Averill DB; Ferrario CM; Figueroa JP; Diz DI; Rose JC; Chappell MC
    Am J Physiol Renal Physiol; 2007 Jan; 292(1):F82-91. PubMed ID: 16896185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of ACE2 and angiotensin-(1-7) in a mouse model of early chronic kidney disease.
    Dilauro M; Zimpelmann J; Robertson SJ; Genest D; Burns KD
    Am J Physiol Renal Physiol; 2010 Jun; 298(6):F1523-32. PubMed ID: 20357030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin-converting enzyme 2-Angiotensin 1-7/1-9 system: novel promising targets for heart failure treatment.
    Kittana N
    Fundam Clin Pharmacol; 2018 Feb; 32(1):14-25. PubMed ID: 28833476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of chronic enalapril treatment on enzymes responsible for the catabolism of angiotensin I and formation of angiotensin II.
    Drummer OH; Kourtis S; Johnson H
    Biochem Pharmacol; 1990 Feb; 39(3):513-8. PubMed ID: 2407244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Counter-regulatory effects played by the ACE - Ang II - AT1 and ACE2 - Ang-(1-7) - Mas axes on the reactive oxygen species-mediated control of vascular function: perspectives to pharmacological approaches in controlling vascular complications.
    Pernomian L; Pernomian L; Baraldi Araújo Restini C
    Vasa; 2014 Nov; 43(6):404-14. PubMed ID: 25339158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.